← k3vl4r
Log inGet started →

KYMR (Kymera Therapeutics Inc) Price Forecast

AI-generated price forecast for Kymera Therapeutics Inc (KYMR) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of September 2026: K3vl4r's AI model currently reads KYMR as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 117.28. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

117.28

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏PostTelegram

KYMR forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~4 weeks out———
Daily~4 months out▼ Down-47.74%0%
Weekly~1.8 years out▼ Down-51.69%—

Latest KYMR news

From the market-news feed the forecasts are read against.

  • Guggenheim Maintains Buy on Kymera Therapeutics, Raises Price Target to $170 · Benzinga · Aug 31
  • Wells Fargo Maintains Overweight on Kymera Therapeutics, Raises Price Target to $151 · Benzinga · Aug 27
  • Kymera Therapeutics (KYMR) Q2 2026 Earnings Call Transcript · Motley Fool · Aug 12
  • Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says · MT Newswires · Aug 10
  • KYMR Q2 Earnings and Revenues Top Estimates on Gilead, Sanofi Payments · Zacks · Aug 6

🔒

See the full KYMR forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

KYMR forecast — frequently asked

Will KYMR go up?

K3vl4r's AI model currently reads KYMR as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the KYMR price prediction for 2026?

K3vl4r's model projects KYMR toward $116.72 over the next ~4 months, a -0.5% move from $117.28. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could KYMR reach?

Over its longest horizon (~~1.8 years), the model's projected target for KYMR is $115.38 (-0.5% vs $115.98). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

GHSTIMACHZNTLMISTITGRCLDXVSTMARDXHCSGCMPXIMMXTVRDKTTA

Will KYMR reach…?

Will KYMR reach $200.00?Will KYMR reach $250.00?Will KYMR reach $500.00?

Or see the full KYMR price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare KYMR

KYMR vs GHKYMR vs STIMKYMR vs ACHKYMR vs ZNTLKYMR vs MISTKYMR vs ITGR

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.